| Authors: |
Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA, USA., Nagar SP; Johnson & Johnson, Horsham, PA, USA., Ghosh S; Johnson & Johnson, Horsham, PA, USA., Fan L; Johnson & Johnson, Horsham, PA, USA., Alegria V; Johnson & Johnson, Horsham, PA, USA., De Braganca KC; Johnson & Johnson, Horsham, PA, USA., Lengil T; Johnson & Johnson, Raritan, NJ, USA., Sharma M; Johnson & Johnson, Raritan, NJ, USA., Pai H; Johnson & Johnson, Raritan, NJ, USA., Perciavalle M; Legend Biotech USA Inc, Somerset, NJ, USA., Maitland J; Analysis Group ULC, Toronto, ON, Canada., Emond B; Analysis Group ULC, Montreal, QC, Canada., Bixby T; Johnson & Johnson, Horsham, PA, USA., Qureshi ZP; Johnson & Johnson, Horsham, PA, USA. zquresh3@its.jnj.com., Fonseca R; Division of Hematology and Medical Oncology, Mayo Clinic in Arizona, Phoenix, AZ, USA. |
